Skip to content

Feasibility of Aerodigestive Stimulation Therapy Trial

Safety and Feasibility of Aerodigestive Stimulation Therapy in Infants With Complex Feeding Difficulties

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06118697
Acronym
FAST
Enrollment
40
Registered
2023-11-07
Start date
2024-02-05
Completion date
2028-11-01
Last updated
2026-05-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Feeding Disorder Neonatal

Keywords

Chronic tube feeding, Gastrostomy, Deglutition, Esophageal manometry

Brief summary

The goal of this study is to demonstrate safety, feasibility, and efficacy of a novel pharyngo-esophageal stimulation technique in restoring aerodigestive and swallowing functions in select infants at-risk for chronic gavage tube feeding or gastrostomy. The main aims are: * To provide consistent activation of deglutition (the process of swallowing), swallowing-airway interactions, and peristalsis in order to decrease the risk of home tube feeding. * To examine whether physical and manometric evidence-guided interventions and biofeedback will improve compliance, minimize parental stress, and increase satisfaction and perceived self-confidence with infant feeding. Participants will have weekly pharyngo-esophageal stimulation guided by High Resolution Impedance Manometry (HRIM) for 4 weeks or until discharge, oral nutritive stimulation of at least 5 mL of prescribed milk with each feed, and weekly parental education and feedback regarding feeding progress.

Detailed description

Stimulation will be provided to the esophagus using esophageal manometry starting at enrollment and then weekly for 4 weeks or until discharge, whichever occurs first. During the 4 weeks of study enrollment, subjects will also be provided nutritive oral feeding therapy with each care with a minimum of 5 mL of their prescribed feed. Feeding evaluations by a study team member will occur once a day during the length of the 4-week trial. The study team will do weekly rounds at the bedside to evaluate feeding progress and study interventions. A feeding plan will be posted at the bedside for clear communication with the care team and family of the subjects.

Interventions

PROCEDUREEsophageal stimulation with high resolution esophageal manometry and nutritive oral feeding therapy

Subjects will be given weekly pharyngo-esophageal stimulation guided by high resolution impedance manometry for 4 weeks. During this time of study intervention, every feed will start with nutritive oral stimulation with at least 5 mL of the infant's prescribed diet.

Sponsors

Sudarshan Jadcherla
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

Mechanistic study design

Eligibility

Sex/Gender
ALL
Age
1 Days to 8 Months
Healthy volunteers
No

Inclusion criteria

* NICU infant ≥37 weeks postmenstrual age not taking full oral feeds * Consult to Neonatal \& Infant Feeding Disorder Program for oral feeding difficulty with diagnostic manometry ordered * Presence of peristaltic and sphincteric reflexes at initial manometry

Exclusion criteria

* Potentially lethal chromosomal anomalies * Craniofacial malformations * Foregut malformations

Design outcomes

Primary

MeasureTime frameDescription
Oral feeding volumes prior to and at the completion of the studyCollected at 4 weeks or prior to dischargeOral feeding volume will be compared prior to the initial manometry study and after the completion of the final manometry study after 4 weeks or prior to discharge, whichever is earliest
Parent surveys4 weeks or prior to dischargeParental questionnaires will be compared from prior to initial esophageal manometry study and after completion of final esophageal manometry study.

Countries

United States

Contacts

CONTACTErika K Osborn
erika.osborn@nationwidechildrens.org6143556667
CONTACTPatty Luzader
patty.luzader@nationwidechildrens.org6143556627
PRINCIPAL_INVESTIGATORSudarshan Jadcherla

Nationwide Children's Hospital

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: May 6, 2026